Citigroup has lowered the price target on MedAssets, Inc
Citigroup has lowered the price target on MedAssets, Inc. (NASDAQ: MDAS) from $20 to $17 and maintains its Hold rating.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Citigroup medassetsPrice Target Analyst Ratings